Between 1986 and 2003, 43 eligible patients were identified, 29 female and 14 male, ranging in age from 32 years to 88 years at the time of diagnosis. The majority of patients were aged between 50 and ...
A widely used treatment for rheumatoid arthritis may offer an unexpected cardiovascular benefit. Methotrexate has been a staple treatment for rheumatoid arthritis for decades, valued for its ability ...
Methotrexate significantly lowers systolic blood pressure in newly diagnosed RA patients compared to sulfasalazine, potentially reducing cardiovascular risk. The study provides prospective comparative ...
“The studies continue to demonstrate a role for the intestinal microbiome in methotrexate responsiveness,” Kristi Kuhn, MD, PhD, a professor of medicine at the University of Colorado Anschutz Medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results